Evidence map›Paper›PMID 32997604›Full record

ReviewAnnual review of pharmacology and toxicology2021

Epigenetic Neuropharmacology: Drugs Affecting the Epigenome in the Brain.

Miklos Toth

Open access · bronzeAbstract readReview
In one paragraph

Review in Annual review of pharmacology and toxicology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. EpiBrain: the brain's epigenetic landscape in a snapshot.bioRxiv : the preprint server for biology · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. The interaction of breastfeeding and genetic factors on childhood obesity.European journal of obstetrics & gynecology and reproductive biology: X · 2024
    Review
  10. Review
  11. Epigenetics as a target to mitigate excess stroke risk in people of African ancestry: A scoping review.Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · 2024
    Article
  12. Neuro-HIV-New insights into pathogenesis and emerging therapeutic targets.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2023
    Article
  13. Review
  14. Review
  15. Neuropharmacological and Antidiabetic Potential ofEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Miklos TothDepartment of Pharmacology, Weill Cornell Medical College, New York, NY 10065, USA; email: mtoth@med.cornell.edu.
Cornell University · US

Funding

The cellular memory of early life adversityR01MH117004 · NIMH · WEILL MEDICAL COLL OF CORNELL UNIV · PI TOTH, MIKLOS · 2020 to 2023
$2.1M
DNA methylation based binary enhancers govern neuronal allocation to coding in the hippocampusR01NS106056 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI TOTH, MIKLOS · 2018 to 2022
$1.8M
The DNA methylation code governing the ensemble representation of morphine-context associationR21DA048635 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI PLEIL, KRISTEN ELIZABETH, TOTH, MIKLOS · 2019 to 2020
$465k
Long-term adverse effect of postnatal fluoxetine in miceR21MH072820 · NIMH · WEILL MEDICAL COLL OF CORNELL UNIV · PI TOTH, MIKLOS · 2005 to 2006
$366k
NIDA NIH HHS R21 DA048635NIMH NIH HHS R01 MH117004NIMH NIH HHS R21 MH072820NINDS NIH HHS R01 NS106056
6 · The paper itself

Abstract

This review explores how different classes of drugs, including those with therapeutic and abuse potential, alter brain functions and behavior via the epigenome. Epigenetics, in its simplest interpretation, is the study of the regulation of a genes' transcriptional potential. The epigenome is established during development but is malleable throughout life by a wide variety of drugs, with both clinical utility and abuse potential. An epigenetic effect can be central to the drug's therapeutic or abuse potential, or it can be independent from the main effect but nevertheless produce beneficial or adverse side effects. Here, I discuss the various epigenetic effects of main pharmacological drug classes, including antidepressants, antiepileptics, and drugs of abuse.

Indexed as

EpigenomePharmaceutical PreparationsBrainDNA MethylationEpigenesis, GeneticHumansNeuropharmacologyPharmaceutical PreparationsbehaviorDNA methylationgene expressionhistone modificationsneuropsychiatric diseasesneuropsychiatric drugs

Identifiers

PMID32997604
PMCPMC9915026
OpenAlexW3090262230

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.